Qube Research & Technologies Ltd - SAB BIOTHERAPEUTICS INC ownership

Back to all holdings Add to watchlist

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103.

Links
Filings
Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2023$47
+9.3%
690.0%0.00%–
Q3 2023$43
-100.0%
69
-99.7%
0.00%
-100.0%
Q1 2022$91,000
-30.5%
24,179
+43.8%
0.00%0.0%
Q4 2021$131,000–16,817–0.00%–
 Download
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
First PREMIER Bank 807,535$5090.16%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 192,027$120,9770.02%
Strategic Financial Concepts, LLC 15,027$9,4670.00%
LGL PARTNERS, LLC 23,000$14,4900.00%
Elgethun Capital Management 9,935$6,3580.00%
PATHSTONE FAMILY OFFICE, LLC 506,513$319,1030.00%
Nadler Financial Group, Inc. 13,750$8,6630.00%
FIRST MANHATTAN CO. LLC. 277,777$174,9990.00%
Gs Investments, Inc. 2,000$1,2600.00%
PEAPACK GLADSTONE FINANCIAL CORP 52,296$330.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders